Early treatment with hepatocyte growth factor improves cardiac function in experimental heart failure induced by myocardial infarction

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 2, 2003, Pages 654-660

  Jin, Hongkui ^a   Yang, Renhui ^a   Li, Wei ^a   Ogasawara, Annie K ^a   Schwall, Ralph ^a   Eberhard, David A ^a   Zheng, Zhong ^a   Kahn, David ^a   Paoni, Nicholas F ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN; SCATTER FACTOR;

ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; HEART FAILURE; HEART FUNCTION; HEART INDEX; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; INDWELLING CATHETER; ISCHEMIC HEART DISEASE; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC VASCULAR RESISTANCE;

ANIMALS; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; HEART FUNCTION TESTS; HEPATOCYTE GROWTH FACTOR; MALE; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0037309308     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.041772     Document Type: Article

References (39)

1. Aoki M, Morishita R, Taniyama Y, Kida I, Moriguchi A, Matsumoto K, and Nakamura T (2000) Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther 7:417-427.
2. Balkovetz DF and Lipschutz (1999) Hepatocyte growth factor and the kidney: it is not just for the liver. Int Rev Cytol 186:225-260.
3. Bottaro DP, Rubin JS, Faletto DL, Chan AML, Kmiecik TE, Vande Woude GF, and Araronson SA (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (Wash DC) 251:802-804.
4. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, and Comoglio PM (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119:629-641.
5. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, Clark WA, Krajewski S, Reed JC, Olivertti G, and Anversa P (1996) Programmed myocardial cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226:316-327.
6. Colucci WS (1996) Apoptosis in the heart. N Engl J Med 335:1224-1226.
7. Comoglio P (1993) Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells, in Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the c-met Receptor (Goldberg ID and Rosen EM eds) pp 131-165, Birkauser-Verlag, Basel, Switzerland.
8. Fliss H and Gattinger D (1996) Apoptosis in ischemia and reperfused rat myocardium. Circ Res 79:949-956.
9. Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S, Tomiya T, Higashio K, and Kurokawa K (1993) Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 18:1443-1449.
10. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Kickoloff BJ, Kinsella JL, Polverini P, and Rosen EM (1993) Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90:1937-1941.
11. Ishii T, Sato M, Sudo K, Suzuki M, Nakai H, Hishida T, Niwa T, Umezu K, and Yuasa S (1995) Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J Biochem 117:1105-1112.
12. Jin H, Yang R-H, Awad TA, Wang F, Li W, Williams S-P, Ogasawara A, Shimada B, Williams PM, de Feo G, and Paoni NF (2001) Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction. Circulation 103:726-742.
13. Kopp JB (1998) Hepatocyte growth factor: mesenchymal signal for epithelial homoeostasis. Kidney Int 54:1392-1393.
14. Mastusmori A, Furukawa Y, Hashimoto, Ono K, Shioi T, Okada M, Iwasaki A, Kishio R, and Sasayama S (1996) Increasing circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem Biophys Res Commun 221:391-395.
15. Matsumoto K and Nakamura T (1996) Emerging multipotent aspects of hepatocyte growth factor. J Biochem 119:591-600.
16. Matsumoto K and Nakamura T (1997) Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 239:639-644.
17. Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT, and Salgia R (2002) Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev 13:41-59.
18. Molnar C, Buratti T, Wiedermann CJ, and Tilg H (2000) Hepatocyte growth factor plasma levels after myocardial infarction are not affected by recombinant tissue-type plasminogen-activator therapy. Eur Cytokine Netw 11:87-90.
19. Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, and Nakamura T (2000) Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 106:1511-1519.
20. Nakamura T, Nawa K, and Ichihara A (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature (Lond) 342:440-443.
21. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Matsumoto K, et al. (1996) Differential regulation of local hepatocyte growth factor, endothelium-specific growth factor, production in vascular cells (Abstract). J Hypertens 14:S70.
22. Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulos GK, and Comoglio PM (1991) Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-Met. Oncogene 6:501-504.
23. Oe S, Hiros T, Fujii H, Yasucjika K, Nishio T, Limuro Y, Morimoto T, Nagao M, and Yamaoka Y (2001) Continuous intravenous infusion of deleted form of hepatocyte growth factor attenuates hepatic ischemia-reperfusion injury in rats. J Hepatol 34:832-839.
24. Ono K, Mastusmori A, Shioi T, Furukawa Y, and Sasayama S (1997) Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation 95:2552-2558.
25. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, and Branuwald E (1979) Myocardial infarct size and ventricular function in rats. Circ Res 44:503.
26. Roos F, Ryan AM, Chamow SM, Bennett GL, and Schwall RH (1995) Induction of liver growth in normal mice by infusion of hepatocyte growth factor/scatter factor. Am J Physiol 268:G380 -G386.
27. Sakakura Y, Kaibori M, Oda M, Okumura T, Kwon AH, and Kamjyama Y (2000) Recombinant human hepatocyte growth factor protects the liver against hepatic ischemia and reperfusion injury in rats. J Surg Res 92:261-266.
28. Soeki T, Tamura Y, Shinobara H, Tanaka H, Bando K, and Fukuda N (2000a) Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease. Heart Vessel 15:105-111.
29. Soeki T, Tamura Y, Shinobara H, Tanaka H, Bando K, and Fukuda N (2000b) Serial changes in serum VEGF and HGF in patients with myocardial infarction. Cardiology 93:168-174.
30. Taniyama Y, Morishita R, Nakagami H, Moriguchi A, Sakonjo H, Shokei K, Matsumoto K, Nakamura T, Higaki J, and Ogihara T (2000) Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation 102:246-252.
31. Ueda H, Nakamura T, Matsumoto K, Sawa Y, Matsuda H, and Nakamura T (2001) A potent cardioprotective role of hepatocyte growth factor in myocardial infarction in rats. Cardiovasc Res 51:41-50.
32. Ueda H, Sawa Y, Matsumoto K, Kitagawa-Sakakida S, Kawahira Y, Nakamura T, Kaneda Y, and Matsuda H (1999) Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart. Ann Thorac Surg 67:1726-1731.
33. Winer J, Jung CK, Shackel I, and Williams PM (1999) Development and validation of real-time quantitative reverse transcription-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270:41-49.
34. Yang RH, Bunting S, Gillett N, Clark R, and Jin H (1995) Growth hormone improves cardiac performance in experimental heart failure. Circulation 92:262-267.
35. Yang RH, Bunting S, Ko A, Keyt BA, Modi NB, Zioncheck TF, Ferrara N, and Jin H (1998) Substantially attenuated hemodynamic responses to Echerichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection. J Pharmacol Exp Ther 284:103-110.
36. Yasuda S, Goto Y, Baba T, Satoh T, Sumida H, Miyazaki S, and Nonogi H (2000) Enhanced secretion of cardiac hepatocyte growth factor from un infarct region is associated with less severe ventricular enlargement and improved cardiac function. J Am Coll Cardiol 36:115-121.
37. Yasuda S, Goto Y, Sumida H, Noguchi T, Baba T, Miyazaki S, and Nonogi H (1999) Angiotensin-converting enzyme inhibition restores hepatocyte growth factor production in patients with congestive heart failure. Hypertension 33:1374-1378.
38. Zarnegar R and Michalopulos GK (1995) The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 129:1177-1180.
39. Zhu Y, Hojo Y, Ikeda U, and Shimada K (2000) Production of hepatocyte growth factor during acute myocardial infarction. Heart 83:450-455.